169 filings
Page 7 of 9
8-K
ci27lr7vsc6e
18 Sep 14
Acucela To Present at the BioCentury NewsMakers in the Biotech Industry Conference
12:00am
8-K
qbyr75
9 Sep 14
Departure of Directors or Certain Officers
12:00am
CT ORDER
jh0f8uouk1ffh601
22 Aug 14
Confidential treatment order
12:00am
8-K
yxxl l7ekmtk5pzj
14 Aug 14
Results of Operations and Financial Condition
12:00am
8-K
hfm64sv kq
12 Aug 14
Revisions to Earnings Forecasts
12:00am
8-K
5kmsz k8v
1 Jul 14
Entry into a Material Definitive Agreement
12:00am
8-K
i54e6d1
6 Jun 14
Submission of Matters to a Vote of Security Holders
12:00am
8-K
ngrtpu1 9m90g
2 Jun 14
Regulation FD Disclosure
12:00am
8-K
hglen0hs4
20 May 14
Regulation FD Disclosure
12:00am
10-Q
p82o5
15 May 14
Quarterly report
12:00am
8-K
dg4xw 9aispyz
15 May 14
Results of Operations and Financial Condition
12:00am
8-K
srtiizz122 iclehz83v
9 May 14
Acucela Provides Update on Emixustat Hydrochloride Clinical Development Program
12:00am
DEF 14A
9gbon f6q8ko3y33yzv
2 May 14
Definitive proxy
12:00am
ARS
ejiux9sbli vmt
1 May 14
Annual report to shareholders
12:00am
10-K
zcdcpgbapa f9qw2f2n
28 Mar 14
Annual report
12:00am
8-K
qvvxl2663vbln t5o
26 Mar 14
Results of Operations and Financial Condition
12:00am
8-K
lxtf72n66u
4 Mar 14
Acucela Completes Enrollment in the Emixustat Hydrochloride Phase 2b/3 Clinical Trial
12:00am
8-K
3kkk0
13 Feb 14
Results of Operations and Financial Condition
12:00am
S-8
tnubi8b5egpnu
7 Feb 14
Registration of securities for employees
12:00am